These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 25589481)

  • 41. Approaches to cardiovascular disease and its treatment.
    Bloomgarden ZT
    Diabetes Care; 2003 Dec; 26(12):3342-8. PubMed ID: 14633826
    [No Abstract]   [Full Text] [Related]  

  • 42. [Prevention of cardiovascular complications associated with diabetes mellitus: hospital emergency department involvement].
    Agudo Villa T; Álvarez-Rodríguez E; Caurel Sastre Z; Martín Martínez A; Merinero Palomares R; Alvarez Rodríguez V; Portero Sánchez I
    Emergencias; 2015 Jun; 27(3):150-154. PubMed ID: 29077306
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Overview of the management of type 2 diabetes.
    Standl E
    Diabetes Metab Rev; 1998 Sep; 14 Suppl 1():S13-7. PubMed ID: 9816482
    [No Abstract]   [Full Text] [Related]  

  • 44. Decade in review-type 2 diabetes mellitus: At the centre of things.
    Ning G
    Nat Rev Endocrinol; 2015 Nov; 11(11):636-8. PubMed ID: 26303599
    [No Abstract]   [Full Text] [Related]  

  • 45. More on carotid atherosclerosis and ezetimibe.
    Paraskevas KI; Mikhailidis DP
    Int Angiol; 2017 Dec; 36(6):580-581. PubMed ID: 28854780
    [No Abstract]   [Full Text] [Related]  

  • 46. Carotid artery stenosis, diabetes mellitus, and TCD4
    Del Porto F; Cifani N; Proietta M; Taurino M
    J Diabetes; 2019 Apr; 11(4):335-336. PubMed ID: 30414241
    [No Abstract]   [Full Text] [Related]  

  • 47. J. Vouillarmet et al. in response to V. Aboyans et al. concerning the article by M. Helfre et al.: Usefulness of a systematic screening of carotid atherosclerosis in asymptomatic people with type 2 diabetes for cardiovascular risk reclassification. Ann Endocrinol (Paris). 2017;78:14-19.
    Vouillarmet J; Helfre M; Grange C
    Ann Endocrinol (Paris); 2018 Apr; 79(2):89-90. PubMed ID: 29530272
    [No Abstract]   [Full Text] [Related]  

  • 48. Therapy of Type 2 Diabetes.
    Landgraf R; Aberle J; Birkenfeld AL; Gallwitz B; Kellerer M; Klein H; Müller-Wieland D; Nauck MA; Reuter HM; Siegel E
    Exp Clin Endocrinol Diabetes; 2019 Dec; 127(S 01):S73-S92. PubMed ID: 31860927
    [No Abstract]   [Full Text] [Related]  

  • 49. [Clinical guidelines for elderly patients with diabetes mellitus].
    Oba K; Nakano H; Igari Y
    Nihon Ronen Igakkai Zasshi; 2010; 47(6):517-21. PubMed ID: 21301140
    [No Abstract]   [Full Text] [Related]  

  • 50. [Treatment guide for diabetes].
    Oba K
    Nihon Ronen Igakkai Zasshi; 2011; 48(6):640-3. PubMed ID: 22322031
    [No Abstract]   [Full Text] [Related]  

  • 51. New IDF Guideline for managing type 2 diabetes in older people.
    Dunning T; Sinclair A; Colagiuri S
    Diabetes Res Clin Pract; 2014 Mar; 103(3):538-40. PubMed ID: 24731476
    [No Abstract]   [Full Text] [Related]  

  • 52. Sex differences in metabolic control.
    Canivet C
    Diabetes Care; 1990 Oct; 13(10):1096-7. PubMed ID: 2209313
    [No Abstract]   [Full Text] [Related]  

  • 53. Correction to: Segment-specific progression of carotid artery atherosclerosis: a magnetic resonance vessel wall imaging study.
    Lu M; Yuan F; Zhang L; Peng P; Qiao H; Cai J; Zhao X
    Neuroradiology; 2020 Feb; 62(2):221. PubMed ID: 31820064
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Type 2 diabetes treatment: more and better].
    Letonturier P
    Presse Med; 2008 Jun; 37(6 Pt 1):990-1. PubMed ID: 18440761
    [No Abstract]   [Full Text] [Related]  

  • 55. Overview and Discussion of the 2017 VA/DoD Clinical Practice Guideline for the Management of Type 2 Diabetes Mellitus in Primary Care.
    Tschanz MP; Watts SA; Colburn JA; Conlin PR; Pogach LM
    Fed Pract; 2017 Oct; 34(Suppl 8):S14-S19. PubMed ID: 30766312
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The perils of polyvascular disease in type 2 diabetes.
    Verma S; Mazer CD; Bhatt DL
    Lancet Diabetes Endocrinol; 2018 Dec; 6(12):914-916. PubMed ID: 30396866
    [No Abstract]   [Full Text] [Related]  

  • 57. Creating diabetes guidelines for the individual not just the illness.
    El Sayed NA; Gabbay R; Umpierrez GE
    Lancet Diabetes Endocrinol; 2022 Apr; 10(4):238-240. PubMed ID: 35255261
    [No Abstract]   [Full Text] [Related]  

  • 58. Point: An alternative hypothesis for why exposure to static magnetic and electric fields treats type 2 diabetes.
    Petersen KF; Rothman DL; Shulman GI
    Am J Physiol Endocrinol Metab; 2021 May; 320(5):E999-E1000. PubMed ID: 33843279
    [No Abstract]   [Full Text] [Related]  

  • 59. Reply to Carter et al.: An alternative hypothesis for why exposure to static magnetic and electric fields treats type 2 diabetes.
    Petersen KF; Rothman DL; Shulman GI
    Am J Physiol Endocrinol Metab; 2021 May; 320(5):E1003. PubMed ID: 33843277
    [No Abstract]   [Full Text] [Related]  

  • 60. Counterpoint: An alternative hypothesis for why exposure to static magnetic and electric fields treats type 2 diabetes.
    Carter CS; Huang SC; Searby CC; Cassaidy B; Miller MJ; Grzesik WJ; Piorczynski TB; Pak TK; Walsh SA; Acevedo M; Zhang Q; Mapuskar KA; Milne GL; Hinton AO; Guo DF; Weiss R; Bradberry K; Taylor EB; Rauckhorst AJ; Dick DW; Akurathi V; Falls-Hubert KC; Wagner BA; Carter WA; Wang K; Norris AW; Rahmouni K; Buettner GR; Hansen JM; Spitz DR; Abel ED; Sheffield VC
    Am J Physiol Endocrinol Metab; 2021 May; 320(5):E1001-E1002. PubMed ID: 33843282
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.